Lysine L-lactylation is an emerging post-translational modification in which a lactyl group is covalently added to lysine residues on proteins, most prominently on histones. This modification creates a mechanistic bridge between cellular metabolism—especially glycolysis and lactate production—and gene regulation. Because lactate levels can rise rapidly under hypoxia, inflammation, and oncogenic signaling, L-lactylation has attracted intense interest as a context-dependent epigenetic regulator. In contrast to better-established marks such as acetylation, phosphorylation, and ubiquitination, L-lactylation directly integrates metabolic intermediates into chromatin dynamics.
At the biochemical level, the lactyl group originates from lactate, typically generated via glycolysis. The addition of lactyl groups to lysines generally depends on lactate availability and is catalyzed by enzymatic systems that can couple lactate to lysine residues. The net effect of L-lactylation is altered chromatin accessibility and recruitment of reader proteins that recognize modified lysines. As a result, L-lactylation can modulate transcriptional programs governing proliferation, differentiation, immune responses, and stress adaptation. Importantly, L-lactylation does not function as a simple on/off switch; it is layered with other chromatin marks and is influenced by the local metabolic state, oxygen tension, nutrient supply, and signaling pathways.
In many experimental settings, increased L-lactylation correlates with enhanced expression of genes that support cell survival and rapid growth. One plausible reason is that tumor microenvironments often exhibit elevated lactate due to altered metabolic rewiring (the Warburg effect) and poor oxygen diffusion. High extracellular lactate can be transported into cells and used as a substrate for intracellular protein lactylation. Consequently, L-lactylation may reinforce oncogenic transcriptional circuits by promoting a chromatin landscape permissive for transcription. Beyond classical cancer biology, L-lactylation has also been implicated in inflammatory activation and immune-cell function. Immune cells undergo profound metabolic shifts during activation, and lactate accumulation can occur in inflamed tissues. By shaping gene expression in macrophages, dendritic cells, and T lymphocytes, L-lactylation may influence cytokine production, metabolic adaptation, and effector functions.
A critical concept is that L-lactylation is reversible. Like other post-translational modifications, it can be counter-regulated by enzymes capable of removing lactyl groups (often discussed as decyl/lacelylation “erasers”). This reversibility implies potential therapeutic leverage: interventions that alter lactate production, lactate transport, or the enzymatic machinery that adds or removes lactyl groups could reshape gene expression patterns without directly editing DNA. Additionally, the functional outcome of L-lactylation may depend on the specific lysine residues modified, the cellular context, and the combinatorial pattern with histone acetylation and methylation. Thus, therapeutic strategies likely require a nuanced understanding of which genomic targets and cell states are most sensitive.
Mechanistically, L-lactylation can affect chromatin structure and recruitment of transcriptional regulators. For histones, incorporation of a lactyl group changes the charge and steric properties of lysine residues, potentially reducing nucleosomal compaction or altering the binding affinity of reader proteins. Readers may include bromodomain-containing factors for acetylated marks or other lactyl-recognizing domains that preferentially bind modified lysines. These interactions can facilitate assembly of transcriptional complexes at promoters and enhancers, leading to changes in RNA polymerase engagement and transcriptional elongation. The modification may also intersect with signaling cascades that regulate transcription, such as pathways responsive to hypoxia or inflammatory cues.
From a therapeutic perspective, several rational intervention points are under investigation. First, targeting metabolic upstream drivers—such as glycolysis, lactate generation, or lactate transport—could lower lactate availability and thereby reduce global or pathway-specific L-lactylation. Second, direct inhibition of “writers” that catalyze lysine lactylation is conceptually attractive because it could achieve selectivity at the modification level. Third, enhancing activity of “erasers” could promote active removal of lactyl marks and restore transcriptional repression in disease states where L-lactylation is pathologically elevated. However, caution is required: lactate is not merely waste; it is a signaling molecule and metabolic substrate, and widespread inhibition could disrupt normal tissue physiology, wound healing, and immune responses.
Biomarker development is another major translational direction. Measuring lactylated histones or lactylated proteomic signatures in tumor tissue, blood, or cerebrospinal fluid could help stratify patients whose diseases are driven by metabolism-associated gene regulation. Such biomarkers might predict response to metabolic therapies, immunotherapies, or targeted epigenetic approaches. Finally, integrating L-lactylation with other epigenetic marks and transcription factor networks could enable more precise therapeutic modeling.
In summary, lysine L-lactylation represents a foundational concept in the emerging field of metabolism-to-epigenetics communication. By coupling lactate availability to chromatin remodeling and transcriptional control, it provides a molecular explanation for how metabolic states can directly reprogram gene expression. Evidence links L-lactylation to cancer progression, immune activation, and disease-associated transcriptional programs, while also highlighting actionable nodes for therapeutic intervention. Source: BISCRM
Cell Proliferation: This review summarizes how lysine L-lactylation links metabolism to gene regulation and disease, and its therapeutic potential.. #breaking
— @BISCRM May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
